Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Flexion Therapeutics Inc.
Headquarters: Burlington, MA, United States of America
Website: N/A
Year Founded: 2007
Status: Acquired
BioCentury | Mar 15, 2023
Emerging Company Profile
Backed by broad syndicate, Mediar takes downstream approach to fibrosis
Academic spinout has drawn $105M to advance first-in-class therapies against three targets
BioCentury | Oct 17, 2022
Management Tracks
Baranowski becomes CEO at Avalyn
Plus new CMO at Ankyra as Kaufman becomes CEO, and updates from Verge, Zentalis, Aviceda and more
BioCentury | Jul 19, 2022
Management Tracks
Sanofi’s Mei becomes CMO at Editas
Plus Ullmann to retire from J&J, and updates from Rome, Nuvation, Evelo and more
BioCentury | Jun 16, 2022
Management Tracks
New CEOs at Anjarium, Cambridge Epigenetix
Plus Sema4’s CFO to step down, and updates from Marengo, Avilar, City of Hope and more
BioCentury | Jan 27, 2022
Management Tracks
Adaptimmune hires Piccina as CCO as it readies for first BLA
Plus Rowe new CSO at Cystic Fibrosis Foundation and updates from Immunovant, Senda, F2G and more
BioCentury | Jan 3, 2022
Product Development
What’s next for voltage-gated sodium channel blockers
Companies dial in subtype selectivity, explore new modalities, and move to more homogeneous trial populations
BioCentury | Oct 12, 2021
Finance
4Q financial markets preview, plus the future of NIH
Plus Novartis CEO’s view of translational science and this week’s Deal in Focus, Flexion-Pacira
BioCentury | Oct 11, 2021
Deals
With CVR, Pacira’s deal for Flexion could nearly double in size
Analgesics company Pacira adds marketed osteoarthritis therapy, with more upside for Flexion shareholders
BioCentury | Oct 8, 2021
Management Tracks
Doyle joins Aro as CMO
Plus: CytoDyn, HealthCap, MinervaX, Oculis and more
BioCentury | Jun 11, 2021
Management Tracks
Slavitt steps down from Biden’s pandemic response team; plus Ocugen, Flexion, Syros, Monte Rosa and more
Andy Slavitt has stepped down as senior adviser to the Biden administration’s coronavirus pandemic response team; the special government employee position limits service time to 130 days.
Items per page:
1 - 10 of 105